Acadia Healthcare Company, Inc. (ACHC), USD, Analysis date: August 23, 2025. Sources: (10-K, Feb 27, 2025), (10-Q, May 13, 2025), (10-Q, Oct 31, 2024), (Earnings Call Transcripts, 2023-2025).

Preliminary moat rating: 3 / 5; estimated durability: ~8–12 years.

| Dimension | Weight % | Raw Score (0–5) | Weighted Contribution |
| :--- | :--- | :--- | :--- |
| Network Effects | 18% | 1 | 1.8 |
| Switching Costs | 15% | 2 | 3.0 |
| Cost Advantage / Unit Cost Leadership | 15% | 3 | 4.5 |
| Intangible Assets / Brand / IP | 12% | 2 | 2.4 |
| Distribution & Efficient Scale | 10% | 4 | 4.0 |
| Data Advantage | 10% | 1 | 1.0 |
| Ecosystem / Platform Effects | 8% | 0 | 0.0 |
| Regulatory / Legal Barriers | 6% | 4 | 2.4 |
| Capital Intensity & Asset Specificity | 4% | 3 | 1.2 |
| Customer Contracts & Revenue Visibility | 2% | 3 | 0.6 |
| **Total** | **100%** | | **20.9** |

### 1) Network Effects
**Reasoning (2–4 sentences)**
Acadia Healthcare's business model does not exhibit strong network effects. The value of its services for a given patient is not directly enhanced by the number of other patients using its facilities. While a larger network of facilities may offer some benefits in terms of brand recognition and potential for data analysis, these are not direct network effects.

**Evidence (1–3 bullets)**
*   The company's growth is driven by expanding its physical footprint (adding beds and facilities) and acquisitions, not by viral user growth or network-based interactions. (10-K, Feb 27, 2025)
*   The company's competitive strengths are listed as its management team, industry trends, national footprint, diversified revenue, and strong financial position, with no mention of network effects. (10-K, Feb 27, 2025)

**Score:** 1 / 5.

### 2) Switching Costs
**Reasoning (2–4 sentences)**
Switching costs for patients are moderate. While patients can technically switch providers at any time, the process of finding a new, suitable treatment facility, transferring medical records, and establishing a relationship with a new care team can be disruptive and emotionally taxing, especially for those with severe or complex conditions. This creates a behavioral lock-in effect.

**Evidence (1–3 bullets)**
*   The company's services have no fixed duration and can be terminated by the patient or facility at any time, indicating a lack of contractual lock-in. (10-Q, May 13, 2025)
*   The nature of Acadia's services, particularly for high-acuity and complex needs patients, implies a significant level of trust and familiarity is built between the patient and the care team, creating a behavioral barrier to switching. (10-K, Feb 27, 2025)

**Score:** 2 / 5.

### 3) Cost Advantage / Unit Cost Leadership
**Reasoning (2–4 sentences)**
Acadia likely benefits from economies of scale in purchasing, back-office functions, and negotiating with suppliers, which could translate to a modest cost advantage over smaller competitors. However, the company has not explicitly claimed a significant per-unit cost advantage in its filings. The company's maintenance capital expenditures are relatively low at approximately 3% of revenue, which contributes to a strong financial position.

**Evidence (1–3 bullets)**
*   Maintenance capital expenditures amounted to approximately 3% of revenue for the year ended December 31, 2024. (10-K, Feb 27, 2025)
*   Salaries, wages, and benefits constitute a significant portion of operating expenses (53.6% of revenue in 2024), indicating that labor costs, which are subject to market pressures, are a major driver of unit costs. (10-K, Feb 27, 2025)

**Score:** 3 / 5.

### 4) Intangible Assets / Brand / IP
**Reasoning (2–4 sentences)**
Acadia's primary intangible assets are its licenses, accreditations, and brand reputation. The company has a portfolio of trade names and certificates of need, which are indefinite-lived intangible assets. However, the company does not hold any significant patents or proprietary technology that would create a strong competitive advantage.

**Evidence (1–3 bullets)**
*   The company's intangible assets not subject to amortization include licenses and accreditations, trade names, and certificates of need. (10-K, Feb 27, 2025)
*   The company's brand is built on its reputation for providing quality care, which is a key factor in attracting patients and referral sources. (10-K, Feb 27, 2025)

**Score:** 2 / 5.

### 5) Distribution & Efficient Scale
**Reasoning (2–4 sentences)**
Acadia has a significant national footprint with 262 behavioral healthcare facilities and approximately 11,850 beds in 39 states and Puerto Rico. This scale and regional density make it a leading platform in a fragmented industry, creating a barrier to entry for smaller players who would need to build a comparable network to compete effectively.

**Evidence (1–3 bullets)**
*   At December 31, 2024, Acadia operated 262 behavioral healthcare facilities with approximately 11,850 beds in 39 states and Puerto Rico. (10-K, Feb 27, 2025)
*   The company's strategy includes expanding its national footprint through acquisitions, joint ventures, and de novo facilities. (10-K, Feb 27, 2025)

**Score:** 4 / 5.

### 6) Data Advantage
**Reasoning (2–4 sentences)**
While Acadia collects a significant amount of patient data, there is no evidence in its public filings that it is leveraging this data to create a significant competitive advantage. The company does not mention any proprietary data analytics or data-driven product improvements that differentiate it from competitors.

**Evidence (1–3 bullets)**
*   The company's public filings do not discuss any data-driven initiatives or competitive advantages derived from its patient data.

**Score:** 1 / 5.

### 7) Ecosystem / Platform Effects
**Reasoning (2–4 sentences)**
Acadia's business model does not involve creating an ecosystem or platform for third-party developers or complementary service providers. Its value proposition is based on providing direct healthcare services, not on creating a network of interconnected products and services.

**Evidence (1–3 bullets)**
*   There is no mention of any third-party developer programs, app marketplaces, or other ecosystem-building initiatives in the company's public filings.

**Score:** 0 / 5.

### 8) Regulatory / Legal Barriers
**Reasoning (2–4 sentences)**
The healthcare industry is highly regulated, and Acadia benefits from significant regulatory barriers to entry. Many states in which the company operates have Certificate of Need (CON) laws that regulate the construction or expansion of healthcare facilities, making it difficult for new competitors to enter the market. The company also needs to comply with numerous licensing, certification, and accreditation requirements.

**Evidence (1–3 bullets)**
*   Many of the states in which Acadia operates facilities have enacted CON laws that regulate the construction or expansion of healthcare facilities. (10-K, Feb 27, 2025)
*   All of the company's facilities must comply with various federal, state, and local licensing and certification regulations and undergo periodic inspections. (10-K, Feb 27, 2025)

**Score:** 4 / 5.

### 9) Capital Intensity & Asset Specificity
**Reasoning (2–4 sentences)**
Building and equipping behavioral healthcare facilities requires significant capital investment. The specialized nature of these facilities makes them less suitable for other purposes, creating a high degree of asset specificity and deterring new entrants who would have to make similar sunk cost investments.

**Evidence (1–3 bullets)**
*   The company's property and equipment, net of depreciation, was valued at USD 2.85 billion as of December 31, 2024. (10-K, Feb 27, 2025)
*   The company's growth strategy involves significant capital expenditures for de novo facilities, joint ventures, and expansions of existing facilities. (10-K, Feb 27, 2025)

**Score:** 3 / 5.

### 10) Customer Contracts & Revenue Visibility
**Reasoning (2–4 sentences)**
While Acadia does not have long-term contracts with its patients, its revenue is relatively predictable due to the recurring nature of its services and the consistent demand for behavioral healthcare. The company's diversified payor mix, with a significant portion of revenue coming from government programs like Medicare and Medicaid, also provides a degree of revenue stability.

**Evidence (1–3 bullets)**
*   For the year ended December 31, 2024, Acadia received 56.5% of its revenue from Medicaid, 26.0% from commercial payors, and 14.2% from Medicare. (10-K, Feb 27, 2025)
*   The services provided by the company have no fixed duration and can be terminated at any time, but the ongoing need for behavioral healthcare services provides a recurring revenue stream. (10-Q, May 13, 2025)

**Score:** 3 / 5.

### Aggregation
Weighted score = (1 * 0.18) + (2 * 0.15) + (3 * 0.15) + (2 * 0.12) + (4 * 0.10) + (1 * 0.10) + (0 * 0.08) + (4 * 0.06) + (3 * 0.04) + (3 * 0.02) = 0.18 + 0.30 + 0.45 + 0.24 + 0.40 + 0.10 + 0.00 + 0.24 + 0.12 + 0.06 = 2.09

Final weighted numeric score: 20.9 / 100

### Mapping
A weighted score of 20.9 falls within the 10 <= Weighted < 30 range, which maps to a moat rating of 1.

### Moat Duration Justification
The estimated moat duration is around 8-12 years. This is primarily supported by the company's strong distribution and efficient scale, as well as the significant regulatory and legal barriers in the healthcare industry. These factors are not easily replicable and provide a durable competitive advantage. However, the lack of strong network effects, switching costs, and intangible assets limits the moat's durability beyond this timeframe.

### Top 3 Moat Erosion Scenarios
1.  **Regulatory Changes:** A significant change in Certificate of Need (CON) laws, which would lower the barrier to entry for new competitors, could erode Acadia's moat.
2.  **Increased Competition:** A consolidation of smaller players or the entry of a large, well-capitalized competitor could challenge Acadia's market position and pricing power.
3.  **Reputational Damage:** A major patient safety incident or a series of negative outcomes could damage the company's brand and lead to a loss of trust from patients and referral sources.

### KPIs to Monitor
*   **Bed Occupancy Rates:** A decline in occupancy rates could indicate increased competition or a decrease in demand for Acadia's services.
*   **Revenue per Patient Day:** A decrease in this metric could signal pricing pressure from competitors or payors.
*   **Same-Facility Revenue Growth:** A slowdown in this growth rate could indicate that the company's existing facilities are facing increased competition or market saturation.
*   **Employee Turnover Rates:** High turnover rates could lead to increased labor costs and a decline in the quality of care.
*   **Number of CON Applications by Competitors:** An increase in CON applications could signal a more competitive landscape.
*   **Changes in Payor Mix:** A shift towards lower-reimbursing payors could impact profitability.
*   **Patient Satisfaction Scores:** A decline in these scores could indicate a deterioration in the quality of care and could lead to reputational damage.
*   **Number of Legal and Regulatory Actions:** An increase in these actions could signal compliance issues and could lead to significant fines and penalties.

### Short Verdict Paragraph
Acadia Healthcare has a narrow moat, primarily derived from its significant scale and the regulatory barriers in the behavioral healthcare industry. The company's large network of facilities creates a barrier to entry for smaller competitors, and the need for Certificates of Need in many states limits the supply of new facilities. However, the company's lack of strong network effects, switching costs, and intangible assets prevents it from having a wider moat. The moat's durability is estimated at 8-12 years, and it could be eroded by regulatory changes, increased competition, or reputational damage. An upgrade to the rating would require evidence of stronger pricing power, a significant and sustainable cost advantage, or the development of a data-driven competitive advantage.

moat rating is 1 / 5